Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027273 · ClinicalTrials.gov registry record · NA
Prevent Return of Stroke Study
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT01027273 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 600 participants.
The verdict
NCT01027273, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.
Interventions
- BEHAVIORAL Prevent Return of Stroke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027273
The ClinicalTrials.gov registry entry for NCT01027273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prevent Return of Stroke is the first listed.
NCT01027273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027273 about?
NCT01027273 is a clinical study titled "Prevent Return of Stroke Study". The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.
What is the current status of trial NCT01027273?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2009-06. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01027273?
The interventions under investigation include: Prevent Return of Stroke (BEHAVIORAL).
Who is sponsoring clinical trial NCT01027273?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.